Travere Therapeutics Stock Quote TVTX - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

17.11

Bid

17.19

Ask

19.00

Volume

0.00 Day's Range 0.00

5.12 52 Week Range 18.60

Market Cap

1.309B

Previous Close

17.11

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,698,135

Shares Outstanding

76,491,485

Dividend Yield

PE Ratio

-11.76

Earnings Per Share (EPS)

-1.46

Revenue

145.24M

Net Profit

-111.4M

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

travere.com

Headquarters

Lewes, Delaware, USA

Founded

Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TVTX. The last closing price for Travere Therapeutics was $17.11. Over the last year, Travere Therapeutics shares have traded in a share price range of $ 5.12 to $ 18.60.

Travere Therapeutics currently has 76,491,485 shares outstanding. The market capitalization of Travere Therapeutics is $1.31 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -11.76.

Overall Flow

Bullish

Net Premium

318k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

FeaturedZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use

FeaturedCBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up

SAN DIEGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced a voluntary pause of enrollment in the Phase 3 HARMONY Study evaluating pegtibatinase for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	3.12	22.3016440315	13.99	18.6	13.93	3656476	16.31243508	CS
4	4.14	31.9198149576	12.97	18.6	12.57	2648463	15.02526174	CS
12	7.26	73.7055837563	9.85	18.6	7.95	1698135	12.72679087	CS
26	10.37	153.857566766	6.74	18.6	5.12	1461682	10.18587868	CS
52	9.49	124.540682415	7.62	18.6	5.12	1455184	8.97417777	CS
156	-8.76	-33.8616157712	25.87	31.65	5.12	1144107	15.54116453	CS
260	-8.04	-31.9681908549	25.15	33.0899	5.12	1068305	16.48747251	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	$ 11.76 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 64.0445 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.99 (0.00%)	0
AACGATA Creativity Global	$ 0.9075 (0.00%)	0
AALAmerican Airlines Group Inc	$ 11.76 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 64.0445 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.99 (0.00%)	0
AACGATA Creativity Global	$ 0.9075 (0.00%)	0
AALAmerican Airlines Group Inc	$ 11.76 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 64.0445 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.99 (0.00%)	0
AACGATA Creativity Global	$ 0.9075 (0.00%)	0